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Introduction
Work-related skin diseases (WSD) are caused or worsened by a professional activity. Occupational skin diseases (OSD) need to fulfil additional legal criteria, which differ from country to country. OSD range amongst the five most frequently notified and recognized occupational diseases (OD) (musculoskeletal diseases, neurologic diseases, lung diseases, diseases of the sensory organs, OSD) all over Europe. 1 In Europe, the incidence of a newly reported case is estimated at 0.5-1 per 1000 workers annually. 2 Prevention of OSD and rehabilitation of fitness for work in patients with WSD is an important objective, which will gain even more importance against the backdrop of the age structure of highly industrialized countries which anticipate an ageing and consequently a decreasing number of qualified workforces.
In the European Union (EU), a politico-economic union of to date 28 member states (Table 1) , several EU directives apply to define shared legal grounds for the work environment, hazardous substances, occupational safety and health (OSH) [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] ( Table 2) . Besides these EU directives, which are legal acts of the European Union that need to be adopted in national law, the management pathways for OSD patients in Europe are differently defined and organized leading to different outcomes.The objective of this survey was to analyse the similarities and differences of current pathways to occupational skin disease prevention, diagnosis, treatment and rehabilitation throughout European countries.
Material and methods

COST (European Cooperation in Science and Technology)
Action TD 1206 (StanDerm) is a scientific cooperation amongst medical experts in the field of OSD from 28 European countries striving for the "Development and Implementation of European Standards on Prevention of Occupational Skin Diseases" (www.s tanderm.eu).
To retrieve information on existing legal grounds, insurance systems and pathways for prevention and medical rehabilitation of OSD in the different countries, a structured initial questionnaire with 45 items (of which 20 required a YES or NO answer) was created as an online databank and its feasibility tested and improved. The final consented spreadsheet questionnaire consisted of 53 items (of which 26 required a YES or NO answer) including the following aspects: country and identification of participating expert (two items), definition and frequency of OSD (four items), insurance provider for OSD (eight items), measures covered by the occupational insurance provider (10 items), treating physician and transferal (four items), notification process (four items), work place visits (two items), national guidelines in the field (two items), diagnostic patch testing (five items), occupational UV radiation-induced skin tumours (nine items), obstacles for rehabilitation (three items). 
Results
Data acquisition
In this survey accomplished in proven experts on OSD we were able to compile data from 24 out of the 28 European Union (EU) member states (Table 1) . Additionally, information was provided by experts from Macedonia (MK), Norway (NO), Serbia (RS) and Switzerland (CH), which are not member states of the EU.
Dualism in health care: specialized health care provision for occupational diseases
In 18 (out of 24) EU member states, to some extent a dualism in health care with a specialized (statutory) insurance against occupational risks (i.e., insurance against work accidents and occupational injuries; statutory social accident insurance) has been implemented, also in the included non-EU countries MK, NO, RS, CH. Switzerland and Serbia. Dualism in this context denotes two different systems of coverage of costs: (i) including diagnostics, treatment and/or prevention for OD vs. (ii) general health care, respectively. The countries with a specialized insurance against occupational risks and the respective official name as well as the legal foundation for this dualism are displayed in Table 3 .
The respective areas of responsibilities (diagnosis and treatment of OD, prevention of OD and/or compensation of OD) of an insurance against occupational risks may vary from one country to the other as is displayed in Table 4 : in 18 of the displayed European countries, diagnostics and treatment of OD is the responsibility of this insurance against occupational risks (however in three of which only under defined specific circumstances). In 19 countries prevention and in 21 countries compensation is covered by the insurance against occupational risks. In countries without this dualism, in general, one national health service (NHS) is covering diagnostics and treatment for both, occupational as well as non-occupational diseases.
Due to the complexity and singularities of country-specific organizational structures some annotations are necessary:
In Austria, concerning educational programmes, there is currently one temporary project within a secondary and tertiary prevention programme for severe OSD in progress.
In Belgium, no statutory insurance against occupational risks exists. However, since 2013, in case of suspected work-related skin lesions diagnostics are covered by the Occupational Disease Fund (ODF) under the following conditions: Health and Safety at Work Act 1974.
*In Belgium; the ODF exclusively covers for employees. Not accessible for self-employed professionals.
†In Finland, diagnostics are paid for by one of about 10 private separate occupational insurance companies in notified cases. If confirmed, treatment is covered as well. ‡In the Netherlands, health care is covered by the general health care law. There is no official specialized health care insurance for OD. However, there are a few specialized (university) institutions which provide diagnosis, treatment and prevention of OSD, without legal frame work. Health care is covered by the general health care law. Extra care including workplace visit, additional patch testing with ingredients/materials from the work place, counselling by a specialized nurse is paid by the employer. However, the employer is not obliged to pay for this.
1 The patient is an employee (not self-employed).
2 The demand for diagnostics is confirmed by a dermatologist or occupational physician. Upon recognition as an occupational disease, outpatient as well as inpatient treatment are covered by the ODF. Depending on the product, also some skin care products are reimbursed (same products as would be covered by the national health care insurance). Educational programmes are not available.
In the Czech Republic, diagnostic costs are not covered by the private commercial insurance company for occupational diseases, which is mandatory for each employee and has to be paid for by the employers. Diagnostic costs are covered by the national health insurance companies. In confirmed cases of occupational disease, costs for the outpatient treatment (consultations and medical treatment) are partly covered by the private commercial insurance company, if not covered by the national health insurance. Treatment of out-/inpatient care is covered by the national health insurance.
In Denmark, all health care (occupational and non-occupational) is paid by the state: A statutory insurance against occupational risks exists (Arbejdsmarkeds Erhvervssygdoms sikring (AES) = Labour Market Insurance). The employers are obliged to have an insurance and pay to the AES. The AES covers the legal handling of a case, payment of prescribed medicine, moisturizers and gloves for home use as well as compensation for loss of work ability and permanent disability. A part of this insurance goes to primary prevention. Educational programmes for secondary prevention are offered for WSD as part of the NHS.
In Hungary, no statutory insurance against occupational risks exists. However, in case of suspected work-related skin lesions, outpatient and inpatient treatment and diagnostics are covered by public health insurance, whereas educational programmes are not covered. The public health insurance fund may ask the employer to reimburse the costs of confirmed OD.
In Finland, no statutory insurance against OD exists (except for farming entrepreneurs). However, in case of suspected work-related skin lesions, diagnostics are reimbursed by a mandatory insurance against OD, which the employer is obliged to take out from any of the private insurance companies which operate in the country. In contrast, in confirmed cases the necessary medical treatment, including the skin care products, are covered and sick leave compensated by the mandatory insurance. In confirmed cases also inpatient treatment can be covered, if needed, but this happens very rarely nowadays. No specific educational or treatment programmes for WSD, as in Germany, are offered.
In Malta, no statutory insurance against occupational risks exists. However, in case of suspected work-related skin lesions diagnostics and in-and outpatient care are covered by the NHS or by the employer directly or as part of group insurance offered to its workers. Where applicable, this will include both medical †In Denmark, diagnosis and treatment of work-related and non-workrelated skin diseases is mostly covered by the NHS, to some extent by the AES. The AES is also in charge for compensation of OD. The institution in charge for prevention is the Labour inspectorate. It inspects and controls that rules are respected, but also works out strategies for prevention within areas of priority. At this point, skin does not seem to be a priority. ‡In Macedonia, the diagnosis and treatment of OD are financially covered by the Health Insurance Fund (0.5% of the budget are allocated for this purpose). Diagnosis and treatment of OD are responsibility of the Ministry of Health, whereas prevention is within the responsibility of the Ministry of Labor and Social Policy and is being payed for by the employers. §In the Netherlands: there is no compensation for OD, except for mesothelioma caused by exposure to asbestos. ¶In Sweden: Diagnosis and treatment in the very most part of cases: social insurance agency (NHS), only to some limited extent: AFA. **UK: Industrial Injuries Disablement Benefit. However, typically occupational skin disease does not cross the threshold for payment through the Industrial Injuries Disablement Benefit system and the patient has to pursue a case through the legal system. fees and relevant medication when an occupational cause is confirmed. Skin care products and educational programmes are not covered. In the Netherlands, there is no official insurance against occupational risks, therefore NA in Table 6 . However, there are diagnostic/therapeutic measures provided by specialized institutions including diagnostics, outpatient treatment and educational programmes. Inpatient treatment and skin care products are not provided by these.
In Portugal, apart from the official institutions dealing with OSD, in every big or medium-sized enterprise the employer has to pay for a private service of occupational physicians to have regular evaluation of the employees done. They can diagnose, treat and report OSD or they can refer to the Department of Dermatology of the NHS to complete the diagnosis. The patients will then be treated as any other patient with a disease. Only if confirmed by the Commission created by the CNPRP [Centro Nacional Protecc ßão contra os Riscos Profissionais (National Center for the Protection against Professional Risks)] that the patient has an OSD, will he/she be exempted from payment within the NHS with regard to consultations, hospital treatments and exams related to their disease. The CNPRP has been just recently renamed into Departamento de Protecc ßão contra os riscos profissionais (DRRP: Department of Protection against Professional Risks).
In Slovenia, according to Article 16 (Education) (i) education and training in relation to health and safety at work is an integral part of education programmes at universities and schools of all types and levels, and (ii) training for safe and healthy work is an integral part of education. However, specific programmes for †In Denmark, for all citizens a part of the prescription medicine is covered by the state (NHS). However, if occupational disease has been diagnosed, the part which the patient was supposed to pay himself, is now payed by the mutual insurance company (AES), as well as skin care products. ‡In Serbia, a statutory insurance against occupational risks specialized on diagnosis and/or treatment of OD does not exist: However, all of the mentioned provisions are covered by the NHS (Serbian Health Insurance). NA: A statutory insurance against occupational risks specialized on diagnosis and/or treatment of OD does not exist: However, some or all of the mentioned provisions may be covered in the same way in countries where there is one undivided NHS.
specific occupational groups after development of an OSD are currently not available. In Sweden, there is no specific enterprise insurance company to provide health care exclusively for OD. All health care (occupational and non-occupational) is paid by county or federal insurance and employers in cooperation at varying time intervals. There is no private or other insurance company involved in providing prevention for contact dermatitis contracted at work apart from the Arbetsmarknadens F€ ors€ akringsaktiebolag (AFA: Labour Market Insurance) Insurance which sponsors research preferably aimed at prevention measures and will also cover some educational programmes and protective equipment. The Swedish Work Health Agency sets the rules for the prevention of work-related diseases, but does not pay for research. Prevention is by law attributed to the employer. The Swedish Social Insurance Agency and AFA Insurance (i.e. two separate entities) will cover sick leave salary and loss of income/disability pension.
In the UK, the NHS provides for the diagnosis and treatment of occupational and non-occupational disease. Some mainly large companies may have in-house or external occupational health provision.
Diagnosis and treatment
The detailed catalogue of different diagnostic and/or therapeutic measures (including treatment of OSD on an outpatient basis vs. inpatient basis, coverage of skin care products as well as educational programmes) provided or paid for by a specialized insurance against occupational risks varies from one country to the other (Table 5 ): In 16 countries the diagnostic procedures, in 15 countries outpatient treatment, in 13 countries in-house hospital patient care, and in 10 countries skin care products are covered by a specific insurance against occupational risks. Specific educational programmes provided by an insurance against occupational risks following occurrence of an WSD/OSD are reported only from eight countries (AT, CH, CZ, DE, HR, MK, SE, SK).
Costs for such insurances against occupational risks involved in the treatment of OSD are covered either • is shared by the employer and the employee (Spain).
Prevention
Concerning prevention (Tables 3 and 4) • the same institution is in charge as for treatment of OD in AT, BE, CH, DE, HR, FR, IT, MK (despite that the same operational institution is in charge, two different sponsors cover for diagnosis/treatment (Health Insurance Fund) vs. prevention (paid by the employers) and PT),
• a different institution is in charge in CZ, ES, NO and SI • there is an institution in charge of prevention of OD, whereas for treatment of OD there is no delimited insurance against occupational risks implemented (in DK, NL, PL, RS, SE (to limited extent) and UK (however, treatment is covered by the NHS)).
• there is no institution in charge for prevention of OD, whereas for treatment of OD there is an insurance against occupational risks implemented (in LT, LU, SK) Cost bearers for institutionalized prevention of OD are either • is shared by the employer and government (taxes) (such as in BE and FI), or
• is financed from multiple sources: the state, but also the mutual insurance company (AES), regions, employers and private insurance companies (such as in DK).
Notification
In most European countries of which we have received information from for this survey, in cases with (suspected or confirmed) OSD a notification report (partly as standardized form) is required in order to notify the insurance provider against occupational risks (AT, BG, CH, DE, DK, ES, FI, FR, HR, HU, IT, LT, LU, MK, NO, PT, RO, RS, SE, SI, SK). However, the point in time when this notification occurs varies:
• in case of suspicion (or proven presence) (AT, 1 In Austria each physician is required by law to report suspected or confirmed OSD to the AUVA. In case of suspicion of OSD also employers and employees can report to the AUVA.
In Germany, two different notification forms are in place for OSD (BK-Nr. 5101): "Hautarztbericht" 2a in case of suspicion of work-relatedness vs. "BK-Anzeige" 2b which is issued if all preventive efforts have failed and specific additional medico-legal criteria are fulfilled (severity/ repeated recurrence, objective necessity for abandoning the occupational activity). In Germany, recognition of work-relatedness alone enables prolonged treatment measures at the expense of the statutory social accident insurance, whereas recognition of a complete OSD (BK-Nr. 5101) requires fulfilment of the above defined medico-legal aspects including giving up the job causing the disease.
3
In Portugal, in theory notification should be initiated whenever an OSD is highly suspected or diagnosed, but is rarely done for the reasons stated below (lack of time of the physicians, fear of job loss and poor compensation). The acquisition of a legal title of OSD with a right to compensation is decided by the commission.
• in case of medical confirmation of OSD/recognition of disability for work by an expert (ES, HR, LT, PL, RS, SE, SI)
• when specific medico-legal criteria are met (DE 2b , FR, RO)
• certainty of occupational impact/failure of preventive measures (LU, DE 2b )
• during preventive medical examinations of workers (MK, SI)
• during examination by the Commission for work ability assessment/when patient is seeking compensation (MK,
A written consent from the patient to this notification is required in France, Germany (only for "Hautarztbericht 1 ") and
Italy. In Switzerland, employee and employer are responsible for the notification of an occupational disease. A physician may notify but with information/consent of the patient; a written consent is not required. In Sweden, it is the patient who initiates the notification. Therefore, without his/her initiative and action no notification occurs.
Recognized occupational skin diseases
Occupational dermatoses, except cancer In contrast to "work-related diseases", which summarize any work-associated disease trigger, an "occupational disease" is a disease, which is caused by the occupational (insured) work and which is, according to the applicable legal frame, also formally recognized as OD. The OD definition varies in different countries according to the national existing legal norms. In most of the 28 European countries included in this survey, the official list of occupational diseases contains OSD which comprise occupational contact dermatitis (OCD) of irritant or allergic pathogenesis and/or occupational contact urticaria (OCU), too (except for IE (no OCU, except for latex), MT (no OCU nor occupational contact allergy), SE (no OCU)). The official names and definitions of the recognized OSD are summarized by country in Table 6 . In Sweden, the main insurance provider, the Social Insurance Agency (SSIA), does not have nor use an official list. AFA either recognizes the SSIA decision regarding OSD. In those cases where the SSIA is not acting at all, which are the majority of cases, AFA uses the categories of the International Labour Organization (ILO) OD list. 20 The experts were also asked to provide information on how many per cent (of all recognized OD) were caused by OSD in their country (Table 7) . It is noteworthy to mention that the results vary depending on the definition of recognized OD and the provision and accessibility of national data bases.
The most frequent manifestation of OSD is hand eczema of various aetiopathologies (irritant, contact allergic, atopic). 21, 22 Only rarely triggered by a single cause, the majority of hand dermatitis cases is multifactorial. 21, 22 It is therefore necessary to identify all causative factors, and establish corresponding avoidance measures in order to achieve sustained improvement and resolution of OSD. However, assessment and recognition of an endogenous component (mostly an atopic skin diathesis or even pre-existing atopic eczema or manifestations of other genetically determined predispositions or diseases, e.g. palmar psoriasis) in work-related skin conditions may vary from one country to the other depending on the national legal framework. Since different countries have different legislation as to dealing with predispositions, there are consequently also remarkable differences in the international literature. Under German law, for example, the individual insured person's status is protected as is at the commencement of the harmful work-related activity. 23 This protection comprises all disease predispositions and constitutional impairments, including also the genetic predisposition for atopic eczema or psoriasis of the hands. Therefore, the causal factor "predisposition" is to be judged just like any other contributing factor. Pursuant to German legislation, consideration of this fact in the legal assessment is mirrored by the term "partial cause". A potential retrospective assessment that the insured person may have "never been suited for the occupational activity (due to his/her constitution)" is therefore under German law not feasible and is of no legal consequence. The key in the occupational expertise is to assess whether the occupational activity represents at least one essential partial cause for the disease (amongst others). If so, an occupational disease (BK 5101) has to be recognized, as long as the other requirements of the Occupational Disease Provision (severity/repeated recurrence, objective necessity for abandoning the occupational activity) are fulfilled. 23, 24 A genetically determined disease which may worsen or become clinically manifest for the first time under specific work-related exposure can be recognized as OD under specific conditions (out of the above mentioned 28 countries) in AT (partly), BE, BG, CH, DE, ES, HR, HU, LT, LU, MK (partly), NL, NO (partly), RO, RS, SE and SI.
Occupational skin cancer (OSC) Recently (effective from 1.1.2015), a novel OD has been introduced in the official list of now 77 OD in Germany, which comprises exclusively squamous cell carcinoma or multiple actinic keratoses (>5 actinic keratoses or field cancerization >4 cm²) induced by occupational exposure to natural UV radiation. 25 Artificial UV exposure as in welding is not part of this or any other listed OD in Germany. The possibility and conditions to recognize UV-induced tumours as an OD in European countries (BG, CH, CZ, DE, DK, ES, HR, IT, NL, PT, RS) are summarized in Table 8 . The legal grounds for recognition of UV light-induced tumours as OD in the respective countries are:
• Bulgaria: list of OD.
• Croatia: UV radiation-induced skin tumours can be defined as OD according to the item in the list of OD related to exposure to non-ionizing radiation. Occupational diseases are diseases caused by an "insurance justified profession" in one of the stated companies.
Skin diseases are only regarded as OSD when and as long as they lead to abandonment of the occupational activities. Belgium 1.202: Huidaandoeningen in het arbeidsmilieu veroorzaakt door stoffen welke niet onder andere posten werden opgenomen.
Huidaandoeningen en huidkanker veroorzaakt door.
There is no specific definition. Occupational disease is considered a disease for which is proved to be consequence of exposure to hazards in the work process and/or the work environment, or a disease which causative factor is related to the process or work and/or working environment, and the intensity and duration of exposure to the hazard is at such a level which is known to cause health impairment. Furthermore there are headings for certain skin diseases:
"Contact irritative dermatitis caused by chemicals."
"Contact allergic dermatitis caused by chemicals." Current OSD management in Europe Table 6 Continued However, also other work-related skin diseases may be accepted as OSD according to article 28 of the said act: "Provided that notwithstanding the fact that any such disease may not be specified in the said Fourth Schedule to this Act, Injury Benefit may nonetheless be payable if the Director is satisfied that the disease developed due to the nature of his work".
The Netherlands There is only an official definition for OD not OSD. However, an overview of all OSD is described by the Netherlands Center for Occupational Diseases (NCvB). Overview of all OSD is described by the Netherlands Center for Occupational Diseases (NCvB). http://www.beroe psziekten.nl/beroepsziekten/huidaandoeningen Norway Yrkessykdomslisten (List of occupational diseases).
Official listed diseases.
Poland There is no separate name or definition for OSD, however, it is immanent in the list of OD as specified in the right column.
An occupational disease is considered "a disease listed in the list of occupational diseases if as the result of the assessment of working conditions it can be stated clearly and with a high probability that it was caused by the action of harmful factors occurring in the workplace or in connection with the method of work." • Denmark: Nr. 960 of 28/06/2016: Skin cancers caused by sunlight.
• Germany: BK 5103 "Squamous cell carcinoma or multiple actinic keratoses induced by natural UV radiation"
• Italy: Skin epitheliomas in UV exposed area of the skin, actinic keratosis and other diseases caused by exposure to UV radiation (also natural). Also melanoma can be recognized as occupational but only in dioxin-exposed individuals and ocular melanoma in solderers. work, where these factors occur and are according to current medical knowledge the cause of the diseases. Based on this, it is possible to qualify natural and artificial UV as a causative factor of occupational skin cancer (OSC), however, so far there has not been admitted any case of UV-induced OSC in the Czech Republic, yet only OSC caused by ionizing radiation. ‡In France, UV light-induced tumours are not listed in the French ODs list, but it is possible that under specific circumstances skin tumours with permanent disabilities (as invasive skin tumours) could be recognized through a complementary system if OSC may result in permanent disabilities (>25%) and if it is directly and primarily due to natural/artificial UV radiation at work. §In Italy, melanoma is only recognized as occupational (i) in welders with ocular melanoma, (ii) skin melanoma (as possibly work-related) in workers exposed to mineral oil. ¶In the UK, a distinction has to be drawn between diagnosis/treatment vs. compensation vs. reporting of an OD (see text). SCC, Squamous cell carcinoma; BCC, Basal cell carcinoma; NA, not applicable (no respective OD in the official list of ODs in this country).
• The Netherlands: The Netherlands Center for Occupational Diseases (NCvB) uses the European Information Notices on OSC and created its own Registration Guidelines on Occupational Diseases.
• • Spain: Cuadro de enfermedades profesionales de la Seguridad Social (official list of occupational diseases of the Social Security system).
• Switzerland: UV light-induced tumours can be defined as OD according to the item in the list of harmful substances and work-related diseases related to exposure to non-ionizing radiation.
• In the UK, a distinction has to be drawn between diagnosis/ treatment vs. compensation vs. reporting of an OD, e.g., occupational cancer is reportable to the Health and Safety Executive (HSE), if the following definition applies: any cancer attributed to an occupational exposure to a known human carcinogen or mutagen (including ionizing radiation). The HSE is aware that UV causes skin cancer, however UV radiation is not explicitly addressed in the above definition. Reporting to the HSE is separate from compensation through Industrial Injuries Disablement Benefit. These are separate from medical provision which is theoretically available to all through the NHS. The list of compensated diseases (https:// www.gov.uk/government/publications/industrial-injuriesdisablement-benefits-technical-guidance/industrial-injuriesdisablement-benefits-technical-guidance) does not specifically mention UV. However, skin cancer (all entities) is recognized by the government in the context of members of the armed services for payment from the War Pensions Scheme. Only in Denmark and Germany a differentiation is made between natural and artificial UV light. In countries, in which melanoma may fulfil criteria of an OD (BG, CZ, DK, IT, NL, PT, RS), the melanoma type has not been further specified to be a prerequisite for recognition as an OD.
First-line care vs. highest level of care of patients with WSD
A requirement for seeing a general practitioner (GP) first in case of an assumed WSD or OSD (before seeing a specialist) is in place in the following countries: BG, CH, DK, HR, IE, LT, NO, RS, SK, SI and depending on the individual insurance system in MT (applicable for the NHS, not for private insurance).
Expert treatment of WSD and OSD is provided by dermatologists or a cooperation of dermatologist and occupational physician, some of which are working in highly specialized centres.
The transfer of a patient with suspected OSD from the first care provider to the expert is usually initiated via the physician's referral in most countries (AT, CH, CZ, DE, DK, ES, FI, FR, HR,   HU, IE, IT, LT, LU, MK, MT, NO, PL, PT, RO, RS, SE, SI, UK) . In Italy and Germany this referral is mandatory (by law or contract). In Germany, for instance, according to §41 of the contract between physicians and the German Statutory Social Accident Insurance it is mandatory to transfer a patient with a suspected OSD to a dermatologist. In Germany and Switzerland also the Statutory Social Accident Insurance (DGUV and SUVA respectively) itself can initiate expert treatment. In Belgium, a medical reference is the reason for referral, in Bulgaria the national health insurance will initiate the expert treatment. In the Netherlands, an employee can only consult an expert centre if there is financial funding by the employer or his own private unemployment insurance. In Spain, the worker himself can request his company to refer him to the occupational public health insurance company (MATEPSS). Similarly, in the Czech Republic, the employee can request the examination in the centre for dermatology and occupational diseases -without a doctor's recommendation. However, the employer too can initiate it.
For the management of WSD and OSD national guidelines are reported from CH, 26 Criteria in medical practice for discontinuation of the causative occupation
In all countries, the primary approach in WSD and OSD is medical and occupational rehabilitation of the patient to avoid job loss. Discontinuation criteria, when occupational rehabilitation measures are declared a failure and the patient is advised to leave for good the workplace where the skin lesions have occurred, are summarized in Table 9 .
Discussion
The EU constitutes a politico-economic union and shares several legal grounds for the work environment, hazardous substances, OSH. However, the organization of prevention, treatment and compensation of OSD is organized very differently in the member states and other European countries. Furthermore, physicians and other health care providers may not be familiar with Table 9 Criteria applied before discontinuation of occupation is recommended these pathways even in neighbouring countries, making the assessment of data on WSD/OSD from other countries hardly comparable or transparent.
Existing definitions for OSD differ between countries, and the point in time when an OSD is being notified varies from first suspicion to when a person had to quit the job. Consequently, the figures of WSD/OSD incorporated in national statistics vary dramatically from one country to the other, since the steering of the notification process is not comparable.
However, medical and occupational rehabilitation, upkeep of working ability and maintenance of the job seem to be common goals in all the surveyed countries.
The most frequently employed discontinuation criterion is the point when all measures of secondary and tertiary prevention have failed (Table 9 ).
In conclusion, the following major obstacles [45] [46] [47] [48] for successful prevention/diagnosis/treatment and rehabilitation of OSD are perceived:
• underreporting (due to patients' fear of job loss; physicians' lack of time)
• lack of standardized programmes for individual secondary and tertiary prevention and therapy of OSD • unawareness by the patient of work-relatedness • fear of the patients to lose their jobs • lack of incentives for dermatologists to diagnose OSD • a too complicated notification system • notification based only on reporting from the patient • dermatologists'/general practitioners' lack of time • lack of knowledge on exposures at workplace.
To use the existing limited resources efficiently, communication between stakeholders and networking between occupational physicians and dermatologists seems important as well as knowledge spreading amongst patients to identify OSD as early as possible before chronicity of the disease has occurred.
Further efforts for standardization and definition of minimum standards on prevention, diagnosis and treatment of WSD and OSD in Europe are necessary. 49 
